Trials / Completed
CompletedNCT02803177
Cell Therapy by Autologous BMC for Large Bone Defect Repair
BMC2012, Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures - a Randomized, Open, Multicentric Study - Phase IIa
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Goethe University · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
In the present phase-II clinical trial the researchers investigate efficacy and proof of concept of the augmentation with preoperatively isolated autologous BMC cells seeded onto ß-TCP in combination with an angle stable fixation (Philos plate®) for the therapy of proximal humeral fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BMC2012 | |
| DEVICE | beta-TCP Chronos® Synthes |
Timeline
- Start date
- 2016-07-02
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2016-06-16
- Last updated
- 2020-01-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02803177. Inclusion in this directory is not an endorsement.